Piraeus Medical, Inc. — SEC Form D Filing

Piraeus Medical, Inc. filed an SEC Form D on April 2, 2026, reporting $3.58M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
April 2, 2026
Amount reported
$3.58M
Round stage
Seed
Industry
Health Care
Website
https://www.piraeusmedical.com/

What the company does

Securities: Equity, Shares of Issuer Preferred Stock and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert.. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Piraeus Medical addresses the challenges related to regulatory compliance and quality assurance in the healthcare sector.

Solution

The company provides innovative solutions and expertise that help healthcare organizations navigate complex regulatory requirements and improve product quality.

Verdict

Investors said yes because Piraeus Medical's narrative was compelling in the context of increasing regulatory scrutiny in healthcare, not because it uniquely differentiated itself from other compliance solutions. They were betting on the growing market demand for regulatory expertise as healthcare organizations sought to streamline compliance, while the limited upside lies in its reliance on regulatory cycles, which can be unpredictable and subject to change.

Source: SEC EDGAR Form D filing